316 related articles for article (PubMed ID: 16421948)
1. CpG motif-independent activation of TLR9 upon endosomal translocation of "natural" phosphodiester DNA.
Yasuda K; Rutz M; Schlatter B; Metzger J; Luppa PB; Schmitz F; Haas T; Heit A; Bauer S; Wagner H
Eur J Immunol; 2006 Feb; 36(2):431-6. PubMed ID: 16421948
[TBL] [Abstract][Full Text] [Related]
2. The sweetness of the DNA backbone drives Toll-like receptor 9.
Wagner H
Curr Opin Immunol; 2008 Aug; 20(4):396-400. PubMed ID: 18656540
[TBL] [Abstract][Full Text] [Related]
3. The DNA sugar backbone 2' deoxyribose determines toll-like receptor 9 activation.
Haas T; Metzger J; Schmitz F; Heit A; Müller T; Latz E; Wagner H
Immunity; 2008 Mar; 28(3):315-23. PubMed ID: 18342006
[TBL] [Abstract][Full Text] [Related]
4. Cross-talk between toll-like receptors 5 and 9 on activation of human immune responses.
Merlo A; Calcaterra C; Mènard S; Balsari A
J Leukoc Biol; 2007 Sep; 82(3):509-18. PubMed ID: 17586660
[TBL] [Abstract][Full Text] [Related]
5. Spatiotemporal regulation of heat shock protein 90-chaperoned self-DNA and CpG-oligodeoxynucleotide for type I IFN induction via targeting to static early endosome.
Okuya K; Tamura Y; Saito K; Kutomi G; Torigoe T; Hirata K; Sato N
J Immunol; 2010 Jun; 184(12):7092-9. PubMed ID: 20483722
[TBL] [Abstract][Full Text] [Related]
6. Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritic cells.
Hartmann G; Battiany J; Poeck H; Wagner M; Kerkmann M; Lubenow N; Rothenfusser S; Endres S
Eur J Immunol; 2003 Jun; 33(6):1633-41. PubMed ID: 12778481
[TBL] [Abstract][Full Text] [Related]
7. Endosomal translocation of vertebrate DNA activates dendritic cells via TLR9-dependent and -independent pathways.
Yasuda K; Yu P; Kirschning CJ; Schlatter B; Schmitz F; Heit A; Bauer S; Hochrein H; Wagner H
J Immunol; 2005 May; 174(10):6129-36. PubMed ID: 15879108
[TBL] [Abstract][Full Text] [Related]
8. Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation.
Guiducci C; Ott G; Chan JH; Damon E; Calacsan C; Matray T; Lee KD; Coffman RL; Barrat FJ
J Exp Med; 2006 Aug; 203(8):1999-2008. PubMed ID: 16864658
[TBL] [Abstract][Full Text] [Related]
9. Impact of modifications of heterocyclic bases in CpG dinucleotides on their immune-modulatory activity.
Vollmer J; Weeratna RD; Jurk M; Davis HL; Schetter C; Wüllner M; Wader T; Liu M; Kritzler A; Krieg AM
J Leukoc Biol; 2004 Sep; 76(3):585-93. PubMed ID: 15218053
[TBL] [Abstract][Full Text] [Related]
10. Ligand-induced conformational changes allosterically activate Toll-like receptor 9.
Latz E; Verma A; Visintin A; Gong M; Sirois CM; Klein DC; Monks BG; McKnight CJ; Lamphier MS; Duprex WP; Espevik T; Golenbock DT
Nat Immunol; 2007 Jul; 8(7):772-9. PubMed ID: 17572678
[TBL] [Abstract][Full Text] [Related]
11. The immunostimulatory activity of unmethylated and methylated CpG oligodeoxynucleotide is dependent on their ability to colocalize with TLR9 in late endosomes.
de Jong SD; Basha G; Wilson KD; Kazem M; Cullis P; Jefferies W; Tam Y
J Immunol; 2010 Jun; 184(11):6092-102. PubMed ID: 20427776
[TBL] [Abstract][Full Text] [Related]
12. CD40-dependent and -independent activation of human tonsil B cells by CpG oligodeoxynucleotides.
Gantner F; Hermann P; Nakashima K; Matsukawa S; Sakai K; Bacon KB
Eur J Immunol; 2003 Jun; 33(6):1576-85. PubMed ID: 12778475
[TBL] [Abstract][Full Text] [Related]
13. Human monocyte-derived dendritic cells express TLR9 and react directly to the CpG-A oligonucleotide D19.
Hoene V; Peiser M; Wanner R
J Leukoc Biol; 2006 Dec; 80(6):1328-36. PubMed ID: 17000899
[TBL] [Abstract][Full Text] [Related]
14. Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction.
Honda K; Ohba Y; Yanai H; Negishi H; Mizutani T; Takaoka A; Taya C; Taniguchi T
Nature; 2005 Apr; 434(7036):1035-40. PubMed ID: 15815647
[TBL] [Abstract][Full Text] [Related]
15. Phosphorothioate-modified TLR9 ligands protect cancer cells against TRAIL-induced apoptosis.
Chiron D; Pellat-Deceunynck C; Maillasson M; Bataille R; Jego G
J Immunol; 2009 Oct; 183(7):4371-7. PubMed ID: 19734228
[TBL] [Abstract][Full Text] [Related]
16. The immunostimulatory activity of CpG oligonucleotides on microglial N9 cells is affected by a polyguanosine motif.
Zhang Z; Guo K; Schluesener HJ
J Neuroimmunol; 2005 Apr; 161(1-2):68-77. PubMed ID: 15748945
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence- and pH-dependent manner.
Rutz M; Metzger J; Gellert T; Luppa P; Lipford GB; Wagner H; Bauer S
Eur J Immunol; 2004 Sep; 34(9):2541-50. PubMed ID: 15307186
[TBL] [Abstract][Full Text] [Related]
18. Bovine toll-like receptor 9: a comparative analysis of molecular structure, function and expression.
Griebel PJ; Brownlie R; Manuja A; Nichani A; Mookherjee N; Popowych Y; Mutwiri G; Hecker R; Babiuk LA
Vet Immunol Immunopathol; 2005 Oct; 108(1-2):11-6. PubMed ID: 16098606
[TBL] [Abstract][Full Text] [Related]
19. Cutting edge: species-specific TLR9-mediated recognition of CpG and non-CpG phosphorothioate-modified oligonucleotides.
Roberts TL; Sweet MJ; Hume DA; Stacey KJ
J Immunol; 2005 Jan; 174(2):605-8. PubMed ID: 15634876
[TBL] [Abstract][Full Text] [Related]
20. Nucleosome-induced neutrophil activation occurs independently of TLR9 and endosomal acidification: implications for systemic lupus erythematosus.
Lindau D; Rönnefarth V; Erbacher A; Rammensee HG; Decker P
Eur J Immunol; 2011 Mar; 41(3):669-81. PubMed ID: 21287547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]